Exclusive: Backed by MIT’s Andrew Lo, Quantile Health raises $6M to bolster gene therapy access

Non-profit and industry investors propose paediatric cancer fund

New study suggests evolutionary forces are behind collective discrimination

New MIT research forecasts effect of two-dose vaccine allocation strategies on cumulative number of infections and death in US

An MIT professor’s rare disease quest ripples throughout biotech

Andrew Lo: It’s Possible to Measure the Impact of Impact Investing

A new wave of drug startups with big portfolios and precarious valuations has burst onto the scene. Welcome to the era of ‘mega biotechs.’

Investors’ chronicle: Gooch & Housego, Braemar, Pennon

MIT experts propose a roadmap for easier passage across the Valley of Death

Opinion: Jack Bogle’s ghost warns about 401(k)s